Results 91 to 100 of about 56,153 (181)

Evaluation of the effects of olopatadine ophthalmic solution, 0.2% on the ocular surface of patients with allergic conjunctivitis and dry eye

, 2008
Purpose: Olopatadine hydrochloride 0.2% (Pataday † , Alcon, Fort Worth, USA) is a topical ocular anti-allergic agent that has shown high rates of efficacy in treating ocular itching, the primary symptom of allergic conjunctivitis, and allows for once ...
Mah, F. S, Kim, T, Torkildsen, G, O'Brien, T   +3 more
core   +1 more source

Evaluation of alcaftadine 0.25% ophthalmic solution in acute allergic conjunctivitis at 15 minutes and 16 hours after instillation versus placebo and olopatadine 0.1%

Clinical Ophthalmology, 2011
Jack V Greiner1,2, Kimberly Edwards-Swanson3, Avner Ingerman41Schepens Eye Research Institute, Boston, MA; 2Department of Ophthalmology, Harvard Medical School, Boston, MA; 3Johnson & Johnson Consumer and Personal Products Worldwide, Skillman, NJ;
Jack V Greiner, Kimberly Edwards-Swanson, Avner Ingerman   +2 more
doaj  

Olopatadine: a drug for allergic conjunctivitis targeting the mast cell

, 2010
IMPORTANCE OF THE FIELD: Ocular allergic diseases are characterized by specific activation of conjunctival mast cells with subsequent release of preformed and newly formed mediators.
LEONARDI, ANDREA, QUINTIERI, LUIGI, Andrea Leonardi, Luigi Quintieri   +3 more
core   +1 more source

Comparative efficacy of bepotastine besilate 1.5% ophthalmic solution versus olopatadine hydrochloride 0.1% ophthalmic solution in allergic conjunctivitis

Journal of Dr. NTR University of Health Sciences
Aim: To compare the efficacy of topical bepotastine 1.5% and olopatadine 0.1% ophthalmic solutions in relieving ocular signs and symptoms of mild to moderate allergic conjunctivitis.
Sunkara Charitha, Kavitha Mandalapu, Bhavya Kadiri, Undrakonda Vivekanand   +3 more
doaj   +1 more source

Comparison of pharmacokinetics and safety characteristics between two olopatadine hydrochloride 5 mg tablet formulations in healthy Korean subjects. [PDF]

Transl Clin Pharmacol, 2021
Kim JH, Lee M, Kim N, Oh TY, Nam SK, Choi YS, Kwon IS, Jung JG, Hong JH.   +8 more
europepmc   +1 more source

Topical Use of Olopatadine and Cyclosporine a in Treatment of Vernal Keratoconjunctivitis

, 2016
Aim: To compare the efficacy and safety of Olopatadine hydrochloride (0.1%) with Cyclosporine A ophthalmic solution (0.05%) in treating the signs and symptoms of VKC. Material and Method: Twenty-five patients with VKC were included in a prospective study.
Fikret, Akata, Zaure, Knatova, Eugeniu, Vieru, Aylin, Kantarci Feride   +3 more
core   +1 more source

Tonicity adjustment of aqueous solutions of drugs. Naphazolin nitrate. Olopatadin hydrochloride. [PDF]

, 2013
Charles University in Prague, Faculty of Pharmacy in Hradec Králové Department of: Pharmaceutical technology Consultant: Doc. PharmDr. Zdeňka Šklubalová, Ph.D. Student: Lucie Kubeczková, DiS.
Kubeczková, Lucie
core  

Comparative efficacy of caffeic acid phenethyl ester (CAPE), olopatadine hydrochloride, and dexamethasone sodium phosphate in experimental allergic conjunctivitis

, 2010
Conclusion: This study demonstrated that 1% CAPE was as clinically efficacious as 0 1% olopatadine and 0 1% dexamethasone. Thus, 1% CAPE may be an alternative to 0 1% olopatadine and 0 1% dexamethasone in the management of acute allergic ...
Erkorkmaz, Ünal, AYDIN, ERDİNÇ, ÖZYURT, HÜSEYİN, DEMİR, HELİN DENİZ, HÜSEYİN ÖZYURT, ERDİNÇ AYDIN, ÜNAL ERKORKMAZ, HELİN DENİZ DEMİR   +7 more
core   +1 more source

Determination of olopatadine in human tears by hydrophilic interaction liquid chromatography-MS/MS method

, 2017
Aim: The objective of the study was development of hydrophilic interaction liquid chromatography-ESI/MS/MS method for the determination of olopatadine in tear matrix. Materials & methods: Separation was performed on Acquity BEH amide column (2.1 x 100 mm,
Knežević, Miroslav, Jančić-Stojanović, Biljana, Mirjana Medenica, Stajić, Ana, Dacić-Krnjaja, Bojana, Jelena Maksić, Miroslav Knežević, Medenica, Mirjana, Maksić, Jelena, Ana Stajić, Bojana Dačić Krnjaja, Biljana Jančić–Stojanović   +11 more
core   +1 more source

Changes in tear function and the ocular surface after topical olopatadine treatment for allergic conjunctivitis: An open-label study

, 2002
Bu çalışma, 23-26 Eylül 2001 tarihlerinde İzmir'de düzenlenen 34. Türkiye Oftalmoloji Kongresi'nde bildiri olarak sunulmuştur.Background Olopatadine hydrochloride 0.1% eye drops represent a new class of anti-allergic agent with combined antihistaminic ...

core   +1 more source